THE RELATIONSHIP OF BRAF V600E MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.
From: 1Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA-21287.
Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Joan C Edwards School of Medicine, Huntington,WV-25701.
Section of Nuclear Medicine, Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA-21287.
- Published Article
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
- Publication Date
Nov 16, 2017
BRAF= B-Raf proto-oncogene, serine/threonine kinase; FDG = Fluorodeoxyglucose; PET = Positron Emission Tomography; CT = Computerized Tomography; SUV = Standardized Uptake Values; GLUT = Glucose Transporter.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/29144823